LETTY ECHEVERRIA: Open Payments
NPI 1104251065 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 21 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $457 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $114 |
| GlaxoSmithKline, LLC. | 3 | $91 |
| Exact Sciences Corporation | 3 | $90 |
| Ardelyx, Inc. | 3 | $84 |
| Corcept Therapeutics | 2 | $47 |
| PFIZER INC. | 1 | $25 |
| Abbott Laboratories | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: The Cologuard Plus Collection Kit, MOUNJARO, IBSRELA, BEXSERO, Korlym, PENMENVY, ZEPBOUND, COMIRNATY.
Industry payments across CA — which companies pay providers there.
